Skip to content
TrustList
Roivant Sciences logo
Venture capital firm

Roivant Sciences

Biopharmaceutical group that builds focused subsidiaries to develop and launch new medicines

Write a review
Visit WebsiteGet introducedWrite a Review
Own this listing? Claim it
Roivant Sciences cover

About Roivant Sciences

Roivant Sciences is a healthcare company that develops medicines and related technologies through a family of small subsidiaries it calls Vants. Each subsidiary concentrates on one therapeutic area, and the parent aligns incentives so that work moves quickly.

Services

  • Drug development: a pipeline of investigational medicines across its subsidiaries.
  • Autoimmune therapies: programmes run through Immunovant and Priovant.
  • Pulmonary disease work: carried out through Pulmovant.
  • Dermatology: a topical treatment for plaque psoriasis in adults, VTAMA, launched in 2022.
  • Computational drug discovery: a platform combining quantum methods, AI and structure data to design molecules.

Key facts

  • Founded: 2014
  • Model: subsidiary companies, each with its own focus
  • Second launch: LISRAYA for adults with dermatomyositis, launched in 2026

Profile written by TrustList from the business's own published information, Oct 2026.

What the business tells TrustList

Founded
2014 (12 years) evidence sent

Ask TrustList to introduce you to Roivant Sciences

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Roivant Sciences

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Roivant Sciences.

Roivant Sciences alternatives

Similar listings buyers compare against this one.

Compare side by side
Operator Collective logo

Operator Collective

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Y Combinator logo

Y Combinator

Startup accelerator and early-stage investor running intensive batches for new technology founders

Sequoia Capital logo

Sequoia Capital

Venture capital firm partnering with founders from first idea through to public listing

Andreessen Horowitz (a16z) logo

Andreessen Horowitz (a16z)

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.